Spirox Bilan de santé

Santé financière contrôle des critères 4/6

Spirox possède un total de capitaux propres de NT$2.2B et une dette totale de NT$116.9M, ce qui porte son ratio d'endettement à 5.3%. Son actif total et son passif total sont NT$2.8B et de NT$560.9M.

Informations clés

5.3%

Ratio d'endettement

NT$116.92m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	NT$1.40b
Fonds propres	NT$2.21b
Total du passif	NT$560.88m
Total des actifs	NT$2.77b

Mises à jour récentes de la santé financière

Recent updates

Optimistic Investors Push Spirox Corporation (TWSE:3055) Shares Up 26% But Growth Is Lacking

Oct 28

Is Spirox (TWSE:3055) Weighed On By Its Debt Load?

Sep 10

Spirox Corporation's (TWSE:3055) Popularity With Investors Under Threat As Stock Sinks 27%

Aug 10

Is Spirox (TWSE:3055) Using Too Much Debt?

Apr 29

Does Spirox (TPE:3055) Have A Healthy Balance Sheet?

Apr 07

Spirox Corporation (TPE:3055) Investors Should Think About This Before Buying It For Its Dividend

Mar 03

Spirox Corporation's (TPE:3055) Shareholders Might Be Looking For Exit

Feb 05

Here's Why We Don't Think Spirox's (TPE:3055) Statutory Earnings Reflect Its Underlying Earnings Potential

Jan 15

Spirox (TPE:3055) Is Making Moderate Use Of Debt

Dec 23

Introducing Spirox (TPE:3055), A Stock That Climbed 76% In The Last Three Years

Nov 27

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 3055 ( NT$1.9B ) dépassent ses passifs à court terme ( NT$405.3M ).

Passif à long terme: Les actifs à court terme de 3055 ( NT$1.9B ) dépassent ses passifs à long terme ( NT$155.5M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 3055 dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de 3055 a été réduit de 28.5% à 5.3% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de 3055 est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de 3055 sur sa dette sont bien couverts par l'EBIT.

Spirox Bilan de santé

Santé financière contrôle des critères 4/6

Informations clés

Mises à jour récentes de la santé financière

Is Spirox (TWSE:3055) Weighed On By Its Debt Load?

Is Spirox (TWSE:3055) Using Too Much Debt?

Does Spirox (TPE:3055) Have A Healthy Balance Sheet?

Spirox (TPE:3055) Is Making Moderate Use Of Debt

Recent updates

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Spirox Corporation to Report Q3, 2024 Results on Nov 06, 2024

Optimistic Investors Push Spirox Corporation (TWSE:3055) Shares Up 26% But Growth Is Lacking

Is Spirox (TWSE:3055) Weighed On By Its Debt Load?

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Spirox Corporation's (TWSE:3055) Popularity With Investors Under Threat As Stock Sinks 27%

Spirox Corporation to Report Q2, 2024 Results on Aug 07, 2024

Dividend of NT$1.01 announced

First quarter 2024 earnings released: NT$0.90 loss per share (vs NT$0.91 profit in 1Q 2023)

Spirox Corporation announced a financing transaction

Is Spirox (TWSE:3055) Using Too Much Debt?

Full year 2023 earnings released: NT$0.49 loss per share (vs NT$2.20 profit in FY 2022)

Spirox Corporation, Annual General Meeting, Jun 19, 2024

Investor sentiment deteriorates as stock falls 18%

New major risk - Share price stability

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 15%

New minor risk - Shareholder dilution

Spirox Corporation and Southport Corporation Launch Non-Destructive SiC Defect Inspection System

Second quarter 2023 earnings: Revenues in line with analyst expectations

Spirox Corporation Announces Appointments to the Risk Management Committee

Spirox International Limited Announces Resignation of Yang, Yao-Chou, Institutional Director

Investor sentiment improves as stock rises 23%

New major risk - Share price stability

New major risk - Earnings quality

Investor sentiment deteriorates as stock falls 20%

Upcoming dividend of NT$1.00 per share at 2.4% yield

New minor risk - Share price stability

Investor sentiment improves as stock rises 20%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: NT$1.02 (vs NT$1.41 loss in 3Q 2021)

Second quarter 2022 earnings released: NT$0.68 loss per share (vs NT$0.90 loss in 2Q 2021)

Upcoming dividend of NT$0.20 per share

First quarter 2022 earnings released: NT$0.76 loss per share (vs NT$1.02 loss in 1Q 2021)

Less than half of directors are independent

Full year 2021 earnings released: NT$3.70 loss per share (vs NT$0.48 loss in FY 2020)

Third quarter 2021 earnings released: NT$1.41 loss per share (vs NT$0.32 profit in 3Q 2020)

Upcoming dividend of NT$0.20 per share

Second quarter 2021 earnings released: NT$0.90 loss per share (vs NT$0.13 profit in 2Q 2020)

First quarter 2021 earnings released: NT$1.06 loss per share (vs NT$0.42 loss in 1Q 2020)

Does Spirox (TPE:3055) Have A Healthy Balance Sheet?

Full year 2020 earnings released: NT$0.48 loss per share (vs NT$0.11 profit in FY 2019)

New 90-day high: NT$35.20

Spirox Corporation (TPE:3055) Investors Should Think About This Before Buying It For Its Dividend

Spirox Corporation's (TPE:3055) Shareholders Might Be Looking For Exit

New 90-day low: NT$29.15

Here's Why We Don't Think Spirox's (TPE:3055) Statutory Earnings Reflect Its Underlying Earnings Potential

New 90-day low: NT$32.15

Spirox (TPE:3055) Is Making Moderate Use Of Debt

Introducing Spirox (TPE:3055), A Stock That Climbed 76% In The Last Three Years

Third quarter 2020 earnings released: EPS NT$0.32

New 90-day high - NT$34.95

First half earnings released

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines